[ad_1]
The other interested population could then be vaccinated gradually starting in the second trimester. “We are currently preparing the vaccination logistics for this,” he explained on Wednesday.
In response to a request from the Ministry of Health, the Ministry of Health emphasized that people who are at higher personal or systemic risk should be vaccinated first.
EU treaty: 300 million doses of vaccine
On the one hand it is about the personnel of health and care facilities, on the other hand it is about those people who have a personal risk of suffering a serious illness or dying from a Covid-19 infection, the Anschober office referred to the population older than 70 years. Years and members of risk groups.
The European Union can buy up to 300 million doses of the promising crown vaccine from BioNTech and Pfizer.
The EU Commission had previously formally approved the framework agreement with the two companies on Wednesday, EU circles confirmed. EU states have the right to acquire rights to the vaccine as soon as it is approved. When the time comes it’s open.
The EU treaty provides for the purchase of 200 million doses of vaccines from BioNTech / Pfizer and an option for 100 million more. According to an EU agreement, future vaccines will be distributed according to population size. Therefore, Austria can expect about two percent of the amount of this framework agreement.
The EU Commission has also signed similar framework agreements with three other vaccine manufacturers: Johnson & Johnson, AstraZeneca and Sanofi-GSK. They also have promising vaccine candidates.
Russia: “Have a very effective vaccine”
BioNTech and Pfizer were the first Western manufacturers to present promising data from their clinical trials on Monday. However, none of the manufacturers have been approved for the European market. It should be requested from the EMA Medicines Agency as soon as sufficient data from clinical trials are available.
The biggest challenge in distributing the BioNTech and Pfizer vaccine is that the vaccine must be transported at a temperature of minus 70 degrees Celsius and cannot be stored in the refrigerator for long.
“We will ship the vaccine at minus 70 degrees, then it will be stored in central locations at minus 70, and when used, it can be stored in the refrigerator for five days or transported at refrigerator temperature,” explained the head of BioNTech. Ugur Sahin in an interview with Reuters. “We will work with this logistics for the first three months and we are also confident that it will work very well in cooperation with the authorities and hospitals.”
More research is being done on how long the vaccine will last at what temperature. More information is expected in December.
Meanwhile, Russia submitted data for its Sputnik V vaccine. This shows 92 percent effectiveness in protecting against Covid-19, Russian state fund RDIF said on Wednesday, citing interim results of a study.
“We have a very effective vaccine,” said Kirill Dmitriev, director of the state fund that funds the research. With “Sputnik V”, Russia was the first country in the world to approve a corona vaccine in August, and thus received criticism from experts because it had only been tested in humans for less than two months.
[ad_2]
